Advances in precision medicine and pharmacogenomics hold promise for reducing drug toxicity. By tailoring treatments based on an individual's genetic profile, it may be possible to predict how a patient will respond to a particular drug and adjust the treatment plan accordingly. Additionally, ongoing research into new drug formulations and delivery methods aims to enhance the efficacy of cancer treatments while minimizing their toxic effects.
